Tag: Aurobindo
Browse our exclusive articles!
Aurobindo Pharma acquisition news: Drugmaker says ‘no binding agreement’ yet
Aurobindo Pharma Ltd. on Wednesday, August 20, clarified that reports of a potential acquisition by the company are premature and should not be relied...
Dr. Reddy’s, Aurobindo face a near-‘lost’ opportunity for an important pipeline drug; Here’s why
The US Food and Drug Administration (FDA) has granted approval to two generic versions of Iron Sucrose, developed by Viatris and Amphastar. According to...
Aurobindo Pharma arm to acquire 100% stake in Lannett Company LLC for $250 million
Hyderabad-based drug maker, Aurobindo Pharma Ltd, on Wednesday (July 30), announced that its wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a...
Aurobindo Pharma arm gets European Commission nod for cancer drug Dazublys
Aurobindo Pharma Ltd's wholly-owned step-down subsidiary, CuraTeQ Biologics, has received marketing authorisation from the European Commission for its trastuzumab biosimilar, Dazublys.This regulatory milestone follows...
